Drug resistance mutations during structured interruptions of HAART in two HIV-1-infected children.

@article{PalaciosSaucedo2011DrugRM,
  title={Drug resistance mutations during structured interruptions of HAART in two HIV-1-infected children.},
  author={Gerardo del Carmen Palacios-Saucedo and Lydia Guadalupe Rivera-Morales and Jos{\'e} Manuel V{\'a}zquez-Guill{\'e}n and Luz Mar{\'i}a S{\'a}nchez and Teresa J. Ramirez and Evangelina Briones and Rocio Ortiz-Lopez and Carlos A. V{\'a}zquez and Cristina Rodr{\'i}guez-Padilla},
  journal={Current HIV research},
  year={2011},
  volume={9 3},
  pages={154-9}
}
Information concerning structured treatment interruptions (STI) of the Highly Active Antiretroviral Therapy (HAART) and their risk for selecting antiretroviral drug resistance in children is scarce. In this study, we searched for antiretroviral drug resistance mutations at the end of five viral rebounds of two children with HIV and a chronically undetectable viral load (VL) who underwent an STI program. The HAART was interrupted for 4 weeks and then restarted and continued for 12 weeks for… CONTINUE READING